期刊
CURRENT PHARMACEUTICAL DESIGN
卷 19, 期 16, 页码 2970-2978出版社
BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/1381612811319160011
关键词
Anti-apoptotic peptide; ischemia-reperfusion; cell penetrating peptides; cardioprotection; systemic delivery; in vivo
资金
- Agence Nationale pour la Recherche [ANR-08-Genopat-031]
- Centre National de la Recherche Scientifique (CNRS)
- Fondation de la Recherche Medicale (FRM)
- Association Francaise contre les Myopathie (AFM)
Acute myocardial infarction (AMI) is a frequent and disabling disease, which is the first cause of cardiovascular mortality worldwide. Infarct size is a major determinant of myocardial functional recovery and mortality after AMI. Limitation of infarct size thus appears as an appropriate strategy to prevent post-ischemic heart failure and improve survival. Reperfusion is the only treatment recommended to reduce infarct size but despite obvious benefits, it may also have deleterious effects called ischemia-reperfusion (IR) injury including myocyte cell death. Proteins involved in the apoptosis cascade generally interact over large surfaces lacking well-defined pockets. Therefore, inhibitory peptides are optimal biomolecules to target these large protein surfaces, they are often more selective to their target than conventional small organic molecules, and they can be tailored for optimal affinity or desired metabolic property. Since peptides do not cross freely biological membranes, they are generally administered in association with cell penetrating peptides (CPPs) and with homing peptides (HPs) for selective organs or tissues targeting. As a first approach in vivo, we made use of the already known BH4 peptidic inhibitor of the mitochondrial apoptotic pathway, which showed cardioprotective properties in a murine model of AMI after a single bolus of intravenous administration. More importantly, similar peptidic strategies and tools are likely to be adaptable to many other situations in which cells have to be protected from apoptosis such as stroke or organ transplantation.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据